CXCL8 and diabetic kidney disease: Until now, few studies had analyzed the effect of JMJD3 inhibition in renal pathology, but some had begun to show its effect to reduce the expression of inflammatory genes (IL6, IL8, IL1β) and prevent p53-dependent apoptosis ameliorating renal dysfunction in diabetic kidney disease [50].